S Science Company, Ltd.
Tokyo Stock ExchangeTotal Valuation
S Science Company, Ltd. carries a market capitalization of 9.06B, placing it among publicly traded companies globally. Its enterprise value stands at 1.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.06B |
| Enterprise Value | 1.52B |
Share Statistics
S Science Company, Ltd. currently has 141.59M shares outstanding.
| Shares Outstanding | 141.59M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
S Science Company, Ltd. trades at a trailing price-to-earnings ratio of 69.78. The price-to-sales ratio is 5.36, and the price-to-book ratio stands at 7.73.
| PE Ratio | 69.78 |
| PS Ratio | 5.36 |
| PB Ratio | 7.73 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 2.51 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 633.15 |
Financial Position
S Science Company, Ltd. maintains a current ratio of 83.44, meaning it holds 83.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 83.44 |
| Quick Ratio | 46.95 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -75.55 |
Financial Efficiency
S Science Company, Ltd. posts a return on equity of 11.85 and a return on invested capital of -6.07.
| Return on Equity (ROE) | 11.85 |
| Return on Assets (ROA) | 1.43 |
| Return on Invested Capital (ROIC) | -6.07 |
| Return on Capital Employed (ROCE) | 12.41 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.76 |
Taxes
Over the trailing twelve months, S Science Company, Ltd. has paid 2.92M in income taxes, reflecting an effective tax rate of 5.88.
| Income Tax | 2.92M |
| Effective Tax Rate | 5.88 |
Stock Price Statistics
S Science Company, Ltd.'s stock has declined approximately -56.46259% over the past 52 weeks. The 50-day moving average sits at 75.40, while the 200-day moving average is 132.13.
| Beta (5Y) | N/A |
| 52-Week Price Change | -56.46259% |
| 50-Day Moving Average | 75.40 |
| 200-Day Moving Average | 132.13 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, S Science Company, Ltd. generated 607.57M in revenue and converted that into 46.67M in net income, yielding earnings per share of 0.33. EBITDA reached -193.32M, while operating income came in at -193.32M.
| Revenue | 607.57M |
| Gross Profit | 31.02M |
| Operating Income | -193.32M |
| Pretax Income | 49.59M |
| Net Income | 46.67M |
| EBITDA | -193.32M |
| EBIT | -193.32M |
| Earnings Per Share (EPS) | 0.33 |
Balance Sheet
Total book value stands at 421.55M, with working capital of 3.04B providing operational flexibility.
| Cash & Cash Equivalents | 1.73B |
| Total Debt | N/A |
| Net Debt | -1.73B |
| Equity (Book Value) | 421.55M |
| Book Value Per Share | 2.98 |
| Working Capital | 3.04B |
Margins
S Science Company, Ltd. operates with a gross margin of 5.11, reflecting its pricing power and cost economics. The operating margin of -31.82 and net profit margin of 7.68 provide insight into operational efficiency.
| Gross Margin | 5.11 |
| Operating Margin | -31.82 |
| Pretax Margin | 8.16 |
| Profit Margin | 7.68 |
| EBITDA Margin | -31.82 |
Stock Splits
S Science Company, Ltd.'s most recent stock split took place on September 26, 2013 with a 10:1 split ratio.
| Last Split Date | 9/26/2013 |
| Split Ratio | 10:1 |
Scores
S Science Company, Ltd. posts an Altman Z-Score of 15.22, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 15.22 |